Clindamycin Hydrochloride Powder CAS 21462-39-5 Raw Materials
Clindamycin Hydrochloride Powder CAS 21462-39-5 Raw Materials
factory
certificate
Home > Antibacterial anti-inflammatory

Clindamycin Hydrochloride Powder CAS 21462-39-5 Raw Materials

Related Attributes


Product details

Clindamycin Hydrochloride Powder Usage and Synthesis.

Clindamycin Hydrochloride is clinically used for the treatment of infections caused by Gram-positive cocci and various anaerobic bacteria.

Clindamycin Hydrochloride Powder treats infections of joints, bone marrow, respiratory tract, and soft tissues of the skin, as well as tonsillitis, pharyngitis, and pneumonia, and it is also useful in the treatment of acne, gynecological inflammation, endocarditis, and pustulosis. 

Various infections such as Clindamycin Hydrochloride Raw Materials is a semi-synthetic antibiotic with broad antibacterial spectrum and strong antibacterial activity, it has significant antibacterial activity against Gram-positive bacteria, and can effectively kill staphylococci, anaerobes, pneumococci and streptococci.

Clindamycin Hydrochloride Powder

Clindamycin Hydrochloride can be successfully used in combination with antibacterial drugs such as amikacin, tobramycin, methicillin, cephalosporins, and fluoroquinolones. 

The most serious adverse reaction is pseudomembranous enteritis, which can occur during treatment or several weeks after administration, and once it occurs can be treated with vancomycin, other gastrointestinal reactions are nausea, bloating, anorexia, diarrhea, etc., with an incidence of 2% to 20%.

Uses and functions of Clindamycin Hydrochloride Powder.

Clindamycin Hydrochloride is a white crystalline powder. Very soluble in water, soluble in methanol, pyridine, slightly soluble in ethanol, almost insoluble in acetone or chloroform, odorless, bitter taste.

Clindamycin Hydrochloride Powder

Clindamycin Hydrochloride Powder is an antimicrobial drug. The antimicrobial spectrum is similar to that of Zeomicin. Use Clindamycin is a derivative of Zeomicin, which is a semi-synthetic antibiotic obtained by replacing the hydroxyl group on the 7-position of Zeomicin with a chlorine atom.

Clindamycin hydrochloride is a derivative of lincomycin, and its bactericidal activity against Aureus and Pneumococcus is many times stronger than that of lincomycin.

Pharmacological Effects of Clindamycin Hydrochloride Powder.

Clindamycin is a semi-synthetic antibiotic with wide antibacterial spectrum and strong antibacterial activity, it has obvious antibacterial activity against Gram-positive bacteria, and can effectively kill staphylococci, anaerobes, pneumococci and streptococci.

Clindamycin Hydrochloride Powder

It has active effects on pathogenic parasites such as Pneumocystis, Toxoplasma, Plasmodium falciparum, etc., and has little adverse reactions.

Clindamycin products currently used in the clinic include clindamycin hydrochloride, clindamycin phosphate and clindamycin palmitate, of which clindamycin phosphate and clindamycin palmitate have no antimicrobial activity per se, and exert antimicrobial and antiparasitic effects after being metabolized in the body to clindamycin.

Clindamycin Hydrochloride Raw Materials is a derivative of Lincomycin, Clindamycin Hydrochloride has a broader antibacterial spectrum than Lincomycin and 4-8 times higher antibacterial activity than Lincomycin.

Clindamycin Hydrochloride Powder

It has antibacterial activity against Gram-positive aerobic bacteria, staphylococci, streptococci, and also against mycoplasma, chlamydia and various anaerobic bacteria.

Production method of Clindamycin Hydrochloride Powder.

Clindamycin is a derivative of Zeomicin, which is a semi-synthetic antibiotic obtained by replacing the hydroxyl group at the 7-position of Zeomicin with a chlorine atom.


Why choose us?

factory

HRK Factory

HRK Factory

About Shipping

shipping

Prev: Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials Next: Fosfomycin Calcium Powder CAS 26472-47-9 Raw Materials

Pharmaceutical Intermediate manufacturers

sales18@interlgroup.com

©2022 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking